Biotech Values

[drbio45]

I note ALNY has not done well thus far with delivery. Merck...dropped their Macular Degeneration JV last year when ALNY was unable to get their med across the single barrier of one cell membrane. I believe some patients suffered some injuries.”
<<

I had heard the same thing but didn't feel it appropriate to start rumors based on heresay. I had heard that the rnai products couldn't get passed the cell membrane but had not heard about injuries.